A mother’s renewed appeal to the government to save her young daughter’s life – July 31, 2015

On December 1, 2014, the small aHUS Australian community celebrated with the PBS listing of Soliris (eculizumab) through Section 100: Highly Specialised Drugs Program for those who meet certain criteria, and the earmarking of $63 million in treatment funding over the next four years. Since then, our celebrations have begun to sour, as aHUS patients currently accessing…

Read More

DigiPharma 2014 – What Does Digital Excellence Look Like?

VIVA! Communications teamed with Princeton Digital to host the third annual Digital Pharma seminar series, entitled ‘What Does Digital Excellence Look Like?’ in Sydney on Wednesday, March 26, 2014. Chaired by Gavin Walsh, General Manager, Princeton Digital, the full-day seminar, which will also be taking place in Melbourne on April 3, 2014, provided Australian pharmaceutical…

Read More